Theriva™ Biologics anuncia la publicación en Nature Medicine de los resultados del ensayo clínico de Fase 2b VIRAGE con VCN-01 en el cáncer de páncreas metastásico

Data ReadoutpositiveVCN-01Positive

AI Analysis

Summary

Theriva Biologics announced publication of Phase 2b VIRAGE trial results with VCN-01 in metastatic pancreatic cancer in Nature Medicine. The publication validates the study and supports continued evaluation of the therapeutic candidate.

Clinical Trial Data

Phase

Outcome Details

Phase 2b VIRAGE trial results published in Nature Medicine, supporting continued evaluation of VCN-01 in metastatic pancreatic cancer

Importance:6/10

Sentiment:

0.75

oncologypancreatic cancerPhase 2bpublicationNature Medicine

Related Companies

$TOVX

Read the original article

Published by GlobeNewswire Clinical Studies on October 1, 2026 2:34 AM

Read Original